EUVIMEDEUVIMED entdecken
Crossref

L26/P-880 Gestational, obstetric, and neonatal outcomes in women aged over 50 undergoing donor in vitro fertilization (d-IVF): A prospective observational study

K. Pantos, K. Sfakianoudis, A. Trypidi, E. Maziotis, A. Pantou, S. Grigoriadis, G. Kokkali, C. Markomichali, T. Griva, E. Baxevani, V.D. Koufonikola, K. Dafopoulos und 1 weitere

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von K. Pantos und 12 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does advancement of chronological age per year increase the risk of gestational, obstetric, and perinatal complications in women aged 50-years and older undergoing donor-IVF? Summary answer Among women aged 50-years and older undergoing donor-IVF, age advancement per year does not associate with higher risk of severe gestational, obstetric, or perinatal complications. What is known already A critical question in medically assisted reproduction (MAR) concerns the maternal age at which the risk of obstetric and perinatal complications becomes clinically significant, potentially rendering d-IVF unsafe. Evidence for addressing this issue remains limited, primarily deriving from small retrospective studies, case series and case reports. As a result, the overall quality of evidence is low, hindering robust clinical decision-making and the formulation of standardized management strategies for women aged 50 years and older. Addressing this knowledge gap is essential for informing practitioners, guiding patient counseling, and optimizing outcomes in this increasingly prevalent population undergoing d-IVF. Study design, size, duration This double-center, prospective, uncontrolled observational study was conducted from 2022 to 2025, enrolling 236 women aged 50 to 69 years undergoing d-IVF. All participants were recruited in accordance with the Declaration of Helsinki, following standard ethical and consent procedures. Participants underwent comprehensive monitoring throughout pregnancy, delivery, and the neonatal period to systematically document complications and adverse events, ensuring rigorous ethical compliance and methodological integrity. Participants/materials, setting, methods The study population consisted of perimenopausal/menopausal women aged 50 years or older. Menopause was defined by the diagnosis of amenorrhea for at least 12 consecutive months. Participants underwent d-IVF using either fresh or cryopreserved donor oocytes and were managed with conventional endometrial preparation protocols. Pregnancy monitoring was conducted in accordance with international clinical guidelines. Neonatal assessment included comprehensive pediatric monitoring up to 12 months. Statistical analysis was performed using R Language for Statistical Purposes. Main results and the role of chance Gestational diabetes mellitus (GDM) was the most frequently observed complication, occurring in 40% of cases (92/236). Hypertensive disorders in pregnancy (HDP) were identified in 20.3% (48/236), preeclampsia in 9.32% (22/236), and fetal growth restriction (FGR) in 3.81% (9/236). Eclampsia was documented in a single case (0.42%). Regarding pediatric follow-up, abnormal neonatal growth was observed in one case at 2, 4, and 6 months, and in two cases at 9 and 12 months. In one case, abnormal growth was accompanied by autism spectrum disorder at 12 months of follow-up. Logistic regression analysis was performed to assess whether the risk of complications increased by advancing maternal age per year, adjusted for pre-existing maternal comorbidities. The analysis demonstrated that each additional year of maternal age beyond 50 years was not associated with an increased risk of delivery-related complications (aOR:0.821;95%CI:0.564–1.062;p-value=0.215), GDM (aOR:0.879;95%CI:0.763–0.991;p-value=0.052), FGR (aOR:0.794;95%CI:0.413–1.131;p-value=0.359), HDP (aOR:0.995;95%CI:0.865–1.121;p-value=0.941), or preeclampsia (aOR:0.985;95%CI:0.798–1.145;p-value=0.985). Additionally, the analysis demonstrated no effect on gestational age (aOR:0.033;95%CI:−0.103–0.169;p-value=0.634), the likelihood of maternal hospitalization (aOR:0.253;95%CI:−0.556–1.06;p-value=0.532), the likelihood of neonatal hospitalization (aOR:0.906;95%CI:0.77–1.04;p-value=0.189), birth weight (aMD:−13.32;95%CI:−48.361–21.721;p-value=0.455), neonatal length (aMD:0.121;95%CI:−0.026–0.268;p-value=0.107), duration of neonatal hospitalization following birth (aMD:0.832;95%CI:0.4–1.73;p-value=0.623), and the 5-minute Apgar score (aMD:−0.0343;95%CI:−0.223–0.155;p-value=0.714). Limitations, reasons for caution Although this study is among the largest prospective observational studies evaluating the safety of d-IVF in women aged 50 years and older, the sample size remains limited, and findings should be interpreted with caution. Larger epidemiological studies across diverse populations are required to confirm these findings and support robust decision-making. Wider implications of the findings Data suggests that strict chronological age limits for d-IVF warrant reconsideration. Decision-making for women aged 50 and above should be guided by comprehensive, individualized health assessment, independent of chronological age, as evidence herein indicates that these women can achieve and sustain a pregnancy without further increased risk of complications. Trial registration number No

Zitieren

APA

Pantos, K., Sfakianoudis, K., Trypidi, A., Maziotis, E., Pantou, A., Grigoriadis, S., Kokkali, G., Markomichali, C., Griva, T., Baxevani, E., Koufonikola, V., Dafopoulos, K., & Simopoulou, M. (2026). L26/P-880 Gestational, obstetric, and neonatal outcomes in women aged over 50 undergoing donor in vitro fertilization (d-IVF): A prospective observational study. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1204

Vancouver

Pantos K, Sfakianoudis K, Trypidi A, Maziotis E, Pantou A, Grigoriadis S, et al. L26/P-880 Gestational, obstetric, and neonatal outcomes in women aged over 50 undergoing donor in vitro fertilization (d-IVF): A prospective observational study. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1204

BibTeX
@article{Pantos2026,
  author = {Pantos, K. and Sfakianoudis, K. and Trypidi, A. and Maziotis, E. and Pantou, A. and Grigoriadis, S. and Kokkali, G. and Markomichali, C. and Griva, T. and Baxevani, E. and Koufonikola, V.D. and Dafopoulos, K. and Simopoulou, M.},
  title = {L26/P-880 Gestational, obstetric, and neonatal outcomes in women aged over 50 undergoing donor in vitro fertilization (d-IVF): A prospective observational study},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1204}
}
Kostenlos starten →